We found that arsenic sulfide has the ability to attract cytotoxic CD8+ T cells into the HCC microenvironment and reduce the expression of THBS1 in tumor through the STAT3-THBS1 signaling pathway. The gene discussed is CD8A; the disease is hepatocellular carcinoma.